UK
NICE recommends Pierre Fabre’s Braftovi in BRAF V600-mutated advanced melanoma
January 21, 2019Sales and Marketing Braftovi, Cancer, NICE, Pierre Fabre, UK, melanoma, pharma
Braftovi (encorafenib), a BRAF kinase inhibitor developed by Pierre Fabre, has been awarded approval in combination with Mektovi (binimetinib) by …
More young people surviving cancer in England, despite significant economic divide
January 17, 2019Medical Communications, Research and Development Cancer, England, UK, health public health, oncology, young people
Mortality and five year survival rates in a range of different cancers among people aged 13-24 improved in England between …
Scotland recommends Roche’s Perjeta for HER2+ metastatic breast cancer
January 15, 2019Manufacturing and Production, Sales and Marketing Breast cancer; Roche; Scotland, NHS, Perjeta, UK, pharma
Breast cancer patients in Scotland are set to receive an additional treatment option, as the Scottish Medicines Consortium announces its …
UK-Japan partnership to see collaboration on incurable diseases, green technology and AI
January 11, 2019Medical Communications AI, Japan, MRC, UK, international partnership, medicine, technology
A new partnership between the UK and Japan will see medical researchers and scientists join forces, in advancing research into …
NICE recommends AstraZeneca’s Fasenra as third treatment option for severe asthma
January 4, 2019Medical Communications, Sales and Marketing AstraZeneca, Fasenra, NHS, NICE, UK, asthma, pharma
It’s good news for both asthma patients and AstraZeneca after UK drug watchdog NICE saw fit to recommend the drugmaker’s …
NICE recommends Lenvima as alternative first-line therapy for advanced liver cancer
December 19, 2018Research and Development, Sales and Marketing Lenvima, NICE, UK, liver cancer, pharma
UK drug watchdog NICE has revealed that it has recommended Eisai’s Lenvima (lenvatinib) for use on the NHS in England …
NHS overcrowding leads to ambulances being turned away
December 17, 2018Sales and Marketing Hopsitals, NHS, UK, health, politics
NHS England’s first weekly report of the winter has revealed that 95% of hospital beds are occupied, while anything above …
Top Ten most popular articles on Pharmafile.com this week!
December 14, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Akorn, Boehringer, Novartis, Pfizer, Trump, UK, pharmafile, top 10
Business seemed to be the theme this week as Akorn’s acquisition of Fresenius fell through, while Boehringer announced a restructuring …
‘Significant’ health outcomes gap still exists in Scotland
December 14, 2018Medical Communications NHS, Scotland, UK, health, inequality
There is a significant gap in health outcomes between the most and least deprived areas of Scotland, a Scottish government …
Data reveals November’s performance was worst on record for NHS
December 14, 2018Medical Communications NHS, NHS England, UK, funding, investment, wait times
November saw the worst A&E performance on record, according to data released by NHS England. The number of patients who …
York-based biotech expands premises after $2.2 million investment
December 14, 2018Medical Communications UK, aptamer, biotech, funding, investment, york science park
The York-based Aptamer Group is set to expand its premises after securing $2.2 million in overseas investment in June of …
Scottish Medicines Consortium approves Verkazia for severe eye condition in children and adolescents
December 12, 2018Research and Development, Sales and Marketing SMC, Santen, Scotland, UK, Verkazia, pharma, vernal keratoconjunctivitis
UK-based pharmaceutical firm Santen has announced that the Scottish Medicines Consortium has awarded approval to its eye drops emulsion Verkazia …
Children being treated for problems with Xanax has increased more than 6 times since last year
December 10, 2018Research and Development, Sales and Marketing UK, drug abuse, misuse, prescriptions, valium, xanax
The number of children being treated for problems with benzodiazepine drugs – which include prescription medicines Xanax and Valium – …
Health Secretary Matt Hancock says government may charter flights to deliver medicines in case of no-deal Brexit
December 7, 2018Medical Communications Matt Hancock, NHS, UK, brexit, no-deal
British health secretary Matt Hancock has said the government is working out ways through which they could charter flights in …
UCB to invest £1 billion into UK R&D
December 6, 2018Manufacturing and Production, Research and Development R&D, UCB, UK, brussels, investment, research
The Brussels-based multinational UCB will invest £1 billion into UK research and development, according to the government’s Life Sciences Sector …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
